These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 12188956)
1. Intracisternal sodium nitroprusside fails to prevent vasospasm in nonhuman primates. Macdonald RL; Zhang ZD; Curry D; Elas M; Aihara Y; Halpern H; Jahromi BS; Johns L Neurosurgery; 2002 Sep; 51(3):761-8; discussion 768-70. PubMed ID: 12188956 [TBL] [Abstract][Full Text] [Related]
2. Effects of a nitric oxide donor on and correlation of changes in cyclic nucleotide levels with experimental vasospasm. Aihara Y; Jahromi BS; Yassari R; Sayama T; Macdonald RL Neurosurgery; 2003 Mar; 52(3):661-7; discussion 666-7. PubMed ID: 12590692 [TBL] [Abstract][Full Text] [Related]
3. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. Pluta RM; Dejam A; Grimes G; Gladwin MT; Oldfield EH JAMA; 2005 Mar; 293(12):1477-84. PubMed ID: 15784871 [TBL] [Abstract][Full Text] [Related]
4. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage. Pluta RM; Afshar JK; Thompson BG; Boock RJ; Harvey-White J; Oldfield EH J Neurosurg; 2000 Jan; 92(1):121-6. PubMed ID: 10616090 [TBL] [Abstract][Full Text] [Related]
5. Role of intraventricular sodium nitroprusside in vasospasm secondary to aneurysmal subarachnoid haemorrhage: a 5-year prospective study with review of the literature. Agrawal A; Patir R; Kato Y; Chopra S; Sano H; Kanno T Minim Invasive Neurosurg; 2009 Feb; 52(1):5-8. PubMed ID: 19247898 [TBL] [Abstract][Full Text] [Related]
6. Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates. Clatterbuck RE; Gailloud P; Tierney T; Clatterbuck VM; Murphy KJ; Tamargo RJ J Neurosurg; 2005 Oct; 103(4):745-51. PubMed ID: 16266059 [TBL] [Abstract][Full Text] [Related]
7. Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm. Raabe A; Zimmermann M; Setzer M; Vatter H; Berkefeld J; Seifert V Neurosurgery; 2002 May; 50(5):1006-13; discussion 1013-4. PubMed ID: 11950403 [TBL] [Abstract][Full Text] [Related]
8. Prevention of cerebral vasospasm by a humanized anti-CD11/CD18 monoclonal antibody administered after experimental subarachnoid hemorrhage in nonhuman primates. Clatterbuck RE; Gailloud P; Ogata L; Gebremariam A; Dietsch GN; Murphy KJ; Tamargo RJ J Neurosurg; 2003 Aug; 99(2):376-82. PubMed ID: 12924713 [TBL] [Abstract][Full Text] [Related]
9. Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. Hino A; Weir BK; Macdonald RL; Thisted RA; Kim CJ; Johns LM J Neurosurg; 1995 Sep; 83(3):503-9. PubMed ID: 7666230 [TBL] [Abstract][Full Text] [Related]
11. Temporal changes in perivascular concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin after subarachnoid hemorrhage. Pluta RM; Afshar JK; Boock RJ; Oldfield EH J Neurosurg; 1998 Mar; 88(3):557-61. PubMed ID: 9488312 [TBL] [Abstract][Full Text] [Related]
12. Sphenopalatine ganglion stimulation for vasospasm after experimental subarachnoid hemorrhage. Takahashi M; Zhang ZD; Macdonald RL J Neurosurg; 2011 Apr; 114(4):1104-9. PubMed ID: 20597600 [TBL] [Abstract][Full Text] [Related]
13. Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys. Kim CJ; Bassiouny M; Macdonald RL; Weir B; Johns LM Stroke; 1996 Sep; 27(9):1629-33. PubMed ID: 8784140 [TBL] [Abstract][Full Text] [Related]
14. Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model. Mori K; Yamamoto T; Miyazaki M; Hara Y; Aiko Y; Koike N; Sakamoto S; Nakao Y; Esaki T J Neurosurg; 2011 Apr; 114(4):1168-75. PubMed ID: 21073257 [TBL] [Abstract][Full Text] [Related]
15. Intracisternal sodium nitroprusside fails to prevent vasospasm in nonhuman primates. Marshman LA Neurosurgery; 2006 Apr; 58(4):E799; author reply E799. PubMed ID: 16575309 [No Abstract] [Full Text] [Related]
16. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Pluta RM Neurol Res; 2006 Oct; 28(7):730-7. PubMed ID: 17164036 [TBL] [Abstract][Full Text] [Related]
17. The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. Edwards DH; Byrne JV; Griffith TM J Neurosurg; 1992 May; 76(5):830-7. PubMed ID: 1314293 [TBL] [Abstract][Full Text] [Related]
18. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. Wolf EW; Banerjee A; Soble-Smith J; Dohan FC; White RP; Robertson JT J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124 [TBL] [Abstract][Full Text] [Related]
19. Novel vasodilatory effect of intracisternal injection of magnesium sulfate solution on spastic cerebral arteries in the canine two-hemorrhage model of subarachnoid hemorrhage. Mori K; Miyazaki M; Hara Y; Aiko Y; Yamamoto T; Nakao Y J Neurosurg; 2009 Jan; 110(1):73-8. PubMed ID: 18834261 [TBL] [Abstract][Full Text] [Related]
20. Type V phosphodiesterase expression in cerebral arteries with vasospasm after subarachnoid hemorrhage in a canine model. Inoha S; Inamura T; Ikezaki K; Nakamizo A; Amano T; Fukui M Neurol Res; 2002 Sep; 24(6):607-12. PubMed ID: 12238630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]